electroCore,

electroCore, Net Debt per Share

The Net Debt per Share of electroCore, (ECOR) as of Oct 18, 2026 is -0.28 USD. In the previous year, Net Debt per Share was -0.98 USD — a change of -71.81% (higher).

Net Debt per Share

-0.28USD

YoY

-71.81%

Last updated:

Net Debt per Share of electroCore, is 2025 -0.28 USD. Net Debt per Share of electroCore, was 2024 -0.98 USD. It decreases by -71.81% higher compared to the previous year.

The electroCore, Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2016
0.86 USD
Jan 1, 2019
-2.76 USD
Jan 1, 2020
-2.47 USD
Jan 1, 2021
-4.24 USD
Jan 1, 2022
-2.13 USD
Jan 1, 2023
-1.21 USD
Jan 1, 2024
-0.98 USD
Jan 1, 2025
-0.28 USD
The electroCore, Net Debt per Share history
YEARNet Debt per ShareYoY
-0.28USD-71.81%
-0.98USD-19.29%
-1.21USD-42.96%
-2.13USD-49.86%
-4.24USD+71.36%
-2.47USD-10.17%
-2.76USD-418.71%
0.86USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Net Debt per Share of electroCore, is -0.28 USD in 2025.

Net Debt per Share of electroCore, changed from -0.98 USD to -0.28 USD, representing a -71.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share electroCore, since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — electroCore,

All Key Metrics — electroCore,